Navigation Links
FDA Issues Complete Response Letter to Biodel Regarding New Drug Application for Linjeta™
Date:11/1/2010

DANBURY, Conn., Nov. 1, 2010 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) requesting additional information regarding the company's new drug application (NDA) for Linjeta™ (human insulin [rDNA origin]) injection 100IU/mL for the treatment of type 1 and type 2 diabetes mellitus to improve glycemic control.

The CRL stated that the FDA's review cycle is complete and that the application cannot be approved in its present form.  Biodel plans to contact the FDA within the coming weeks to request a meeting to discuss the company's next steps and requirements for approval of Linjeta™.

The CRL included comments related to clinical trials, statistical analysis and chemistry, manufacturing and controls.

With regard to efficacy, the FDA stated that, in the type 1 trial analysis, excluding data from India was post-hoc and therefore not sufficient for establishing conclusive evidence of efficacy.  In the type 2 trial analysis, the FDA acknowledged that non-inferiority was established in the completer population but stated that non-inferiority was not established in the intent-to-treat population because the agency did not consider a post-hoc modification of the statistical model as establishing conclusive evidence of efficacy.  With regard to safety, the FDA commented that unequivocal non-inferiority needs to be achieved in order to compare the risk of hypoglycemia.  The FDA requested that the company conduct two new phase 3 clinical trials using the commercial formulation, one in patients with type 1 diabetes and the other in patients with type 2 diabetes, to establish efficacy and safety as related to hypoglycemia and toleration.

The FDA also requested additional data related to stability and manufacturing.  In
'/>"/>

SOURCE Biodel Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
2. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
3. European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
4. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
5. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
6. QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Womens Health Issues
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.
8. Lupus Under the Spotlight: U.S. Congress Shows Support for Womens Health Issues
9. European Unions CHMP Issues Positive Opinion on Sugammadex
10. Newly Published Study Shows OPKOs siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
11. Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015  Amgen (NASDAQ: ... commenced termination of its participation in the ... (LON:AZN, STO:AZN and NYSE: AZN ).  ... development for patients with moderate-to-severe plaque psoriasis, ... was based on events of suicidal ideation ...
(Date:5/22/2015)... HILL, N.C. , May 22, 2015 /PRNewswire/ ... critical to pharmaceutical brand recognition and success. ... LLC conducted a study to provide pharmaceutical and ... of investment (FTEs and budget) that are being ... Pharmaceutical and biotech marketing managers can utilize this ...
(Date:5/22/2015)... 22, 2015 Electrophysiologist Kevin Makati, M.D. ... to Boston, MA to ... Heart Rhythm Society conference. These scientific sessions drew ... the ideas, people and technology that propel their ... hybrid, minimally invasive cardiac operation that combines the ...
Breaking Medicine Technology:Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5Effective Marketing Services Group Critical for Pharmaceutical Brand Recognition 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 3
...   " The   Obama administration will offer loans ... in adopting technology to improve healthcare quality." ... records . " What is Europe,s ... IT programmes and initiatives are currently taking place across the entire ...
... ? Sosei Group Corporation ("Sosei"; TSE Mothers ... Pharma Co., Ltd. ("Activus") is to receive a grant ... New Energy and Industrial Technology Development Organization (NEDO), an ... and Industry (METI) as a part of their FY2011 ...
Cached Medicine Technology:Innovations in E-Health & Informatics Europe: The Need for a European EHealth Strategy 2Sosei to Receive Grant from NEDO's FY2011 Innovation Promotion Programme for Development of Innovative Ophthalmic Solutions 2Sosei to Receive Grant from NEDO's FY2011 Innovation Promotion Programme for Development of Innovative Ophthalmic Solutions 3
(Date:5/25/2015)... May 25, 2015 According to a ... market growth in hip external fixation market is driven ... U.S. population and advancements in infection prevention technologies. As ... fractures are currently accounting for the largest total number ... with falls and accidents. As a result, the average ...
(Date:5/25/2015)... Join Fiona's Soccer Camp at Novato High School's ... Irish National Player, Fiona O'Sullivan will be on site to ... her coaching style. Fiona has three camps running this summer ... at Lynwood Elmentary School (June 15-19) and Hill Recreation Center ... 6th, 2015 - 1:00-3:00pm. Bring a Soccer Ball, Cleats and ...
(Date:5/24/2015)... Pacific Prime has announced that they have launched ... at the cost of individual international health insurance. Titled: The Cost ... the cost of health insurance in six top expat destinations, which ... Hong Kong , Singapore , ... the UK , Article 2 presents an ...
(Date:5/24/2015)... Scientists with Cardno ChemRisk, a scientific ... compliance issues that may have raised the risk of ... just posted an article on the research. Click ... found airborne asbestos levels well above OSHA safety guidelines ... 2011. , “Asbestos compliance sampling data associated with the ...
(Date:5/24/2015)... Arizona (PRWEB) May 24, 2015 ... former Millennial Media strategy executive Jay Krihak as ... Medicx looks to ramp up its expertise and ... of the Pharmaceutical and Health sectors. , Krihak ... tech executive. Most recently, Krihak led sales planning ...
Breaking Medicine News(10 mins):Health News:DePuy Synthes and Stryker Lead Orthopedic External Fixation Trauma Device Market Due to Increased Hip Fractures in the U.S. 2Health News:DePuy Synthes and Stryker Lead Orthopedic External Fixation Trauma Device Market Due to Increased Hip Fractures in the U.S. 3Health News:US Sports Camps and Nike Soccer Camps Offer Complimentary Instructional Clinic with Fiona's Soccer Camp 2Health News:Pacific Prime Releases 2nd Article of Cost of Health Insurance Report 2Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Medicx Media Solutions Expands Executive Team 2
... have reported that the Australian Therapeutic Goods Administration (TGA) has ... from September. // ,Early June had seen the ... the vaccine, Gardasil, in the United States for girls ... TGAs approval was confirmed by CSL. The vaccine was invented ...
... a Pharmac decision to fund long-acting insulin, that has been ... that purchases drugs announced yesterday that it would fund the ... its trade name, Lantus. ,Wayne McNee, Pharmac chief ... million, reduces the risk of hypo glycaemia which could lead ...
... dead in Livingston, southern Zambia, a major nesting area for ... of the birds, and samples were collected to be sent ... executive director of Poultry Association said a delay on the ... our industry as people are now avoiding eating chickens". ...
... pressure are at a higher risk for cardiovascular ... ,In a study released today, "Impaired stress induced ... African American youth at risk of hypertension," researchers ... youth at risk for deteriorating endothelial function. Endothelial ...
... formulated a plan to combat the spread of avian ... was agreed to during the one-day meeting of Economic ... charge of agriculture, health, livestock, environment and integration. ... said that the ministers "examined and adopted the plan ...
... New reports indicate that patients who are suffering from cancer ... a year. //The new figures indicate that there is delay ... conducted at 32 hospitals show that people suffering from aggressive ... months. It was also reported that in an unfortunate instance, ...
Cached Medicine News:Health News:Bird Flu In Zambia-Panic Among Locals 2Health News:Mental Stress Linked To Higher Risk Of Heart Disease 2Health News:Increasing Delays In Treatments For Cancer Patients 2
Inquire...
... for Subcellular Fractionation, Proteins and ... (30,000 rpm) with fixed-angle rotor ... up to 85 mL • ... to 40° C • Rotors ...
... The compact Allegra X-22 Series is up to ... With a library of 11 rotors, the Allegra X-22 ... Features: Only 18 inches / 46 ... to 22,065 x g 3 different ways to ...
... Fractionation, Proteins and Viruses • ... with fixed-angle rotor • Spin ... 85 mL • Operating temperature ... C • Rotors certified by ...
Medicine Products: